SB 431542: Selective ALK5 Inhibitor for TGF-β Pathway Research

Executive Summary: SB 431542 is a selective, ATP-competitive inhibitor of the type I TGF-β receptor ALK5, with an IC₅₀ of 94 nM, effectively blocking Smad2 phosphorylation and downstream signaling (APExBIO). This compound is widely utilized in cellular and animal models for studying TGF-β-driven processes including proliferation, differentiation, and immune modulation (Wang et al., 2020). SB 431542 also inhibits ALK4 and ALK7, but not ALK1/2/3/6, ensuring pathway selectivity (SB-431542.com). It is soluble in DMSO (≥19.22 mg/mL) and ethanol (≥10.06 mg/mL), but insoluble in water. Recent studies highlight its utility in dissecting EMT and anti-tumor immune processes (AImmuno.com).

Biological Rationale

The transforming growth factor-β (TGF-β) signaling pathway regulates cell proliferation, differentiation, migration, and immune responses (Wang et al., 2020). Dysregulation of TGF-β is implicated in cancer, fibrosis, and chronic inflammatory diseases. TGF-β signals through type I (ALK5/TGFBR1) and type II receptors, leading to phosphorylation of receptor-regulated Smads (Smad2/3), which translocate to the nucleus and regulate gene transcription. Epithelial-to-mesenchymal transition (EMT), a process critical for cancer metastasis and tissue fibrosis, is driven by TGF-β/Smad2 signaling. In endometriosis, overactive TGF-β1/Smad2 contributes to pathological EMT and cellular invasion (Wang et al., 2020). Precise chemical inhibition of ALK5 is therefore essential for dissecting both normal and pathological TGF-β responses.

Mechanism of Action of SB 431542

SB 431542 is a small-molecule, ATP-competitive inhibitor of activin receptor-like kinase 5 (ALK5), the canonical type I TGF-β receptor (APExBIO). It inhibits ALK5 kinase activity with an IC₅₀ of 94 nM, preventing phosphorylation of Smad2. SB 431542 also inhibits ALK4 and ALK7, but exhibits minimal activity against ALK1, ALK2, ALK3, and ALK6, allowing selective interrogation of TGF-β/ALK5-driven pathways (SB-431542.com). By blocking Smad2 activation, SB 431542 disrupts nuclear translocation of Smad complexes and transcriptional regulation of TGF-β target genes. This results in inhibition of TGF-β-induced EMT, suppression of cell proliferation in malignant glioma lines, and modulation of immune cell differentiation (Wang et al., 2020).

Evidence & Benchmarks

• SB 431542 inhibits ALK5 kinase activity with an IC₅₀ of 94 nM in cell-free assays (APExBIO).
• Prevents TGF-β-induced phosphorylation and nuclear accumulation of Smad2 in multiple cell types (Wang et al., 2020).
• Suppresses TGF-β–induced EMT in endometrial and carcinoma cells (Wang et al., 2020).
• Reduces proliferation of D54MG, U87MG, and U373MG glioma cell lines by inhibiting thymidine incorporation without inducing apoptosis (SB-431542.com).
• Enhances cytotoxic T lymphocyte activity in murine tumor models, suggesting immune modulatory effects (AImmuno.com).
• Stable in DMSO at concentrations ≥19.22 mg/mL for several months at -20°C, provided solutions are not stored long-term (APExBIO).

Applications, Limits & Misconceptions

SB 431542 is extensively used in research on cancer, fibrosis, regenerative medicine, and immunology. It is applied in vitro to study TGF-β-driven EMT, stem cell differentiation, and immune cell modulation. In vivo, it has been used for preclinical studies of anti-tumor immunity and fibrosis models.

• Widely adopted for dissecting TGF-β/Smad2 signaling in cancer and fibrosis (STATS5.com).
• Standard in protocols for inhibiting EMT and evaluating anti-metastatic interventions (AmenamevirSMOL.com).
• Useful in immuno-oncology for enhancing cytotoxic T lymphocyte responses through dendritic cell modulation (AImmuno.com).
• Research-grade only; not approved for diagnostic or therapeutic use (APExBIO).

Common Pitfalls or Misconceptions

• SB 431542 is not effective against ALK1, ALK2, ALK3, or ALK6 kinases; it is selective for ALK5, ALK4, and ALK7 only (SB-431542.com).
• Long-term storage of SB 431542 solutions at room temperature or above -20°C leads to degradation (APExBIO).
• Does not induce apoptosis in most cell lines at standard working concentrations; antiproliferative effects are Smad2-dependent (Wang et al., 2020).
• Compound is insoluble in water and requires DMSO or ethanol for stock solutions (APExBIO).
• Not suitable for clinical or veterinary use; strictly for research applications (APExBIO).

This article expands on SB 431542: Precision ALK5 Inhibitor for TGF-β Pathway Research by providing detailed evidence summaries and explicit protocol boundaries; further, it updates cellular solubility parameters discussed in SB 431542: Advanced ALK5 Inhibitor for TGF-β Pathway Research.

Workflow Integration & Parameters

SB 431542 is supplied as a solid, research-grade compound. It is insoluble in water but dissolves readily in DMSO (≥19.22 mg/mL) and ethanol (≥10.06 mg/mL) with ultrasonic agitation and warming to 37°C (APExBIO). For optimal results, prepare fresh solutions or store aliquots at -20°C. Avoid repeated freeze-thaw cycles and long-term storage of working solutions. For in vitro assays, typical working concentrations range from 1–10 μM, depending on the cell type and endpoint. In animal studies, intraperitoneal administration protocols require solvent compatibility and dose titration to avoid precipitation (SB-431542.com). Always consult current literature and the SB 431542 product page for up-to-date handling and safety recommendations.

Conclusion & Outlook

SB 431542, distributed by APExBIO, is a robust and well-characterized ALK5 inhibitor that has become the gold standard for dissecting the TGF-β signaling pathway in preclinical research. Its high selectivity, reproducible activity, and compatibility with diverse workflows enable precise investigation of TGF-β-driven EMT, proliferation, and immune modulation. Ongoing advances in TGF-β biology and therapeutic targeting will continue to rely on SB 431542 for mechanistic and translational studies. For complete product specifications and ordering, refer to the official SB 431542 (A8249) kit page.